{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:02:56Z","timestamp":1787022176400,"version":"build-2736575974"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001637","name":"Trinity College Dublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>While previous studies have examined the link between Type 2 Diabetes Mellitus (T2DM) and cognitive function in middle-aged adults, no review has explored the long-term effects on cognition of T2DM when diagnosed at midlife. This review aims to investigate any association between T2DM and its metabolic correlates during midlife and measures of cognitive function, spanning from midlife into later life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Electronic databases (EMBASE, Medline, CINAHL, Web of Science) were explored from their establishment until December 2023 to identify studies exploring the link between T2DM in midlife (40\u201365 years) and cognitive function. T2DM was defined based on ESC and AHA criteria, encompassing diabetes status, FBG, HbA1c levels, and MetS presence. Cognitive function in mid and\/or later life was categorised into functioning sub-domains, with tests selected to reflect predominant cognitive functions utilised. A random-effects meta-analysis was performed, and study quality assessed using the AXIS tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 151 studies of moderate to high quality. Studies were independently screened in a step-by-step process, with a subset of studies that met the criteria selected for inclusion in a meta-analysis. Due to limited availability of raw data for cognitive measures at later life, meta-analysis was conducted on studies assessing cognitive function at midlife only. In the case of later life, the majority of longitudinal studies reported negative relationships between midlife T2DM and cognitive function, specifically in the modalities of executive function and global cognition; findings for memory were conflicting. Qualitive assessment of 107 studies where cognitive function was assessed at midlife found no association between it and midlife T2DM. However, meta-analysis of 10 studies revealed a negative impact of T2DM on memory (MD\u2009=\u2009\u22120.19; 95% CI\u2009=\u2009\u22120.26 to \u22120.11; I2\u2009=\u200925%), executive function (MD\u2009=\u2009\u22120.14; 95% CI\u2009=\u2009\u22120.25 to \u22120.04; I2\u2009=\u20090%), and global cognition (MD\u2009=\u2009\u22120.26; 95% CI\u2009=\u2009\u22120.34 to \u22120.17; I2\u2009=\u20090%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study highlights the impact of midlife T2DM on a variety of cognitive domains from midlife onwards, suggesting that timely diagnosis of T2DM and its careful management may be an important strategy in preserving cognitive function through the lifespan. Given the contrast in results from qualitative and quantitative analysis that we report in the case of midlife cognitive function, we also emphasise the value of combining both methodological approaches where possible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0327408","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:26:03Z","timestamp":1764959163000},"page":"e0327408","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["The influence of type 2 diabetes and its metabolic correlates in middle-aged adults on cognition at mid and later life; A systematic review and meta-analysis"],"prefix":"10.1371","volume":"20","author":[{"given":"Oisin C.","family":"Joyce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliodhna","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6171-8751","authenticated-orcid":true,"given":"David","family":"Mocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9255-0848","authenticated-orcid":true,"given":"\u00c1ine M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"10","key":"pone.0327408.ref001","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort","volume":"74","author":"RF Gottesman","year":"2017","journal-title":"JAMA Neurol"},{"issue":"10027","key":"pone.0327408.ref002","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"pone.0327408.ref003","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.2337\/db10-0539","article-title":"Accelerated progression from mild cognitive impairment to dementia in people with diabetes","volume":"59","author":"W Xu","year":"2010","journal-title":"Diabetes"},{"key":"pone.0327408.ref004","doi-asserted-by":"crossref","first-page":"108078","DOI":"10.1016\/j.diabres.2020.108078","article-title":"Diabetes and global ageing among 65-99-year-old adults: findings from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"162","author":"A Sinclair","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"pone.0327408.ref005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"GJ Biessels","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"pone.0327408.ref006","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"RA Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"pone.0327408.ref007","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/nyas.12807","article-title":"Impact of diabetes on cognitive function and brain structure","volume":"1353","author":"A Moheet","year":"2015","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"pone.0327408.ref008","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S2213-8587(13)70088-3","article-title":"Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions","volume":"2","author":"GJ Biessels","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"pone.0327408.ref009","article-title":"Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: the Fremantle Diabetes Study","author":"DG Bruce","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"pone.0327408.ref010","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa815","article-title":"Diabetes, brain infarcts, cognition, and small vessels in the Canadian alliance for healthy hearts and minds study","volume":"106","author":"HC Gerstein","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"pone.0327408.ref011","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1253\/circj.CJ-11-0121","article-title":"Neurovascular coupling in cognitive impairment associated with diabetes mellitus","volume":"75","author":"M Mogi","year":"2011","journal-title":"Circ J"},{"key":"pone.0327408.ref012","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fnagi.2018.00270","article-title":"Reduced regional cerebral blood flow relates to poorer cognition in older adults with type 2 diabetes","volume":"10","author":"KJ Bangen","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"pone.0327408.ref013","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00125-018-4778-9","article-title":"Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study","volume":"62","author":"ML Callisaya","year":"2019","journal-title":"Diabetologia"},{"issue":"4","key":"pone.0327408.ref014","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s11011-018-0223-5","article-title":"Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin","volume":"33","author":"G Bernardes","year":"2018","journal-title":"Metab Brain Dis"},{"issue":"12","key":"pone.0327408.ref015","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.2337\/dc13-0143","article-title":"Brain atrophy in type 2 diabetes: regional distribution and influence on cognition","volume":"36","author":"C Moran","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"pone.0327408.ref016","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/1479164119848093","article-title":"Oxidative stress and endothelial dysfunction are associated with reduced cognition in type 2 diabetes","volume":"16","author":"ON Groeneveld","year":"2019","journal-title":"Diab Vasc Dis Res"},{"issue":"3","key":"pone.0327408.ref017","first-page":"155","article-title":"Non-pharmacological interventions for cognition in patients with type 2 diabetes mellitus: a systematic review","volume":"113","author":"AH Dyer","year":"2020","journal-title":"QJM"},{"issue":"2","key":"pone.0327408.ref018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1017\/S1355617718001042","article-title":"Type 2 diabetes and cognitive functions in middle age: a meta-analysis","volume":"25","author":"E Pelimanni","year":"2019","journal-title":"J Int Neuropsychol Soc"},{"issue":"6","key":"pone.0327408.ref019","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00592-020-01648-9","article-title":"The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis","volume":"58","author":"Y You","year":"2021","journal-title":"Acta Diabetol"},{"key":"pone.0327408.ref020","article-title":"Midlife hypertension is a risk factor for some, but not all, domains of cognitive decline in later life: a systematic review and meta-analysis","author":"O Joyce","year":"2023","journal-title":"J Hypertens"},{"issue":"39","key":"pone.0327408.ref021","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"N Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"pone.0327408.ref022","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"issue":"12","key":"pone.0327408.ref023","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies","volume":"12","author":"E von Elm","year":"2014","journal-title":"Int J Surg"},{"issue":"12","key":"pone.0327408.ref024","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"MJ Downes","year":"2016","journal-title":"BMJ Open"},{"issue":"8","key":"pone.0327408.ref025","doi-asserted-by":"crossref","first-page":"2325967119862750","DOI":"10.1177\/2325967119862750","article-title":"Cardiovascular health of retired field-based athletes: a systematic review and meta-analysis","volume":"7","author":"C McHugh","year":"2019","journal-title":"Orthop J Sports Med"},{"key":"pone.0327408.ref026","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511779633","volume-title":"The Cambridge dictionary of statistics","author":"BS Everitt","year":"2010"},{"issue":"11","key":"pone.0327408.ref027","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JPT Higgins","year":"2002","journal-title":"Stat Med"},{"key":"pone.0327408.ref028","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-9-10","article-title":"Overstating the evidence: double counting in meta-analysis and related problems","volume":"9","author":"SJ Senn","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"pone.0327408.ref029","doi-asserted-by":"crossref","first-page":"00028","DOI":"10.3389\/fspor.2020.00028","article-title":"Associations between factors across life and one-legged balance performance in mid and later life: evidence from a British birth cohort study","volume":"2020","author":"JM Blodgett","year":"2020","journal-title":"Front Sports Act Living"},{"issue":"6","key":"pone.0327408.ref030","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4239\/wjd.v8.i6.286","article-title":"Statin use and cognitive function in middle-aged adults with type 1 diabetes","volume":"8","author":"KA Nunley","year":"2017","journal-title":"World J Diabetes"},{"issue":"4","key":"pone.0327408.ref031","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/brainsci10040249","article-title":"Trajectories of immediate and delayed verbal memory in the Spanish general population of middle-aged and older adults","volume":"10","author":"I Bayes-Marin","year":"2020","journal-title":"Brain Sci"},{"issue":"3","key":"pone.0327408.ref032","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/02813432.2020.1802140","article-title":"The association between diabetes and cognitive changes during aging","volume":"38","author":"S Papunen","year":"2020","journal-title":"Scand J Prim Health Care"},{"issue":"1","key":"pone.0327408.ref033","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2337\/dc14-1196","article-title":"Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose","volume":"38","author":"G Erus","year":"2015","journal-title":"Diabetes Care"},{"issue":"10248","key":"pone.0327408.ref034","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"G Livingston","year":"2020","journal-title":"Lancet"},{"issue":"10452","key":"pone.0327408.ref035","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission","volume":"404","author":"G Livingston","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"pone.0327408.ref036","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1017\/S1355617713001483","article-title":"Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains","volume":"20","author":"P Palta","year":"2014","journal-title":"J Int Neuropsychol Soc"},{"issue":"9","key":"pone.0327408.ref037","article-title":"Relationship between acute glucose variability and cognitive decline in type 2 diabetes: a systematic review and meta-analysis","volume":"18","author":"H Chi","year":"2023","journal-title":"PLoS One"},{"issue":"6","key":"pone.0327408.ref038","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s12529-024-10274-6","article-title":"The Effects of type 2 diabetes on cognitive performance: a review of reviews","volume":"31","author":"T Sola","year":"2024","journal-title":"Int J Behav Med"},{"issue":"2","key":"pone.0327408.ref039","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(08)70021-8","article-title":"Cognition and diabetes: a lifespan perspective","volume":"7","author":"GJ Biessels","year":"2008","journal-title":"Lancet Neurol"},{"key":"pone.0327408.ref040","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.108.533075","article-title":"Diabetes: vascular or neurodegenerative: an epidemiologic perspective","volume":"40","author":"LJ Launer","year":"2009","journal-title":"Stroke"},{"key":"pone.0327408.ref041","first-page":"103758","article-title":"Prevalence of hypertension in Type-2 diabetes mellitus","volume":"78","author":"MW Naseri","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"pone.0327408.ref042","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S2213-8587(14)70148-2","article-title":"Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review","volume":"3","author":"SLC Geijselaers","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"pone.0327408.ref043","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200817","article-title":"Clinically relevant changes for cognitive outcomes in preclinical and prodromal cognitive stages: implications for clinical Alzheimer trials","volume":"99","author":"E Borland","year":"2022","journal-title":"Neurology"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0327408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:26:10Z","timestamp":1764959170000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0327408"}},"subtitle":[],"editor":[{"given":"Suzanne","family":"Estaphan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0327408","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}